Peabody owes shareholders some clarification and transparency then. He needs to step up and address these issues. That can be done with more detailed updates about business plan execution to assure shareholders. The silence is deafening.
Looks like the me they aren't fighting the suits and just settling. So, I see no reason this latest one will be any different. Shareholder confidence is in the crapper right now. Like I said, I'm out until I see a significant shift in the company's attitude and their execution/delivery. This is the OTC and the first few whiffs I get that reek of deceiving shareholders, I'm out.
Peabody should recognize that and react accordingly instead of behaving in a pattern common to other scams and failed ventures in the OTC world. Shareholder confidence/assurance is deteriorating quickly and with that, the PPS.
Market Data 
Markets 
AI
